Crestor Cost in Florida 2026: Prices, Medicaid Coverage, and Savings Options

What Does Crestor Actually Cost in Florida in 2026?

Brand Crestor (rosuvastatin calcium, AstraZeneca) carries an average wholesale price near $290 per month in Florida for a 30-tablet supply of the 10 mg or 20 mg strength. That figure is the starting point for negotiations, not what most patients pay. Generic rosuvastatin from manufacturers like Teva, Amneal, and Sun Pharma retails for roughly $15 per month at large Florida chains, and GoodRx coupons applied at Walmart, Publix, or CVS typically reduce the out-of-pocket cost to $8, $12 per month.

Brand vs. Generic Price Breakdown

The FDA granted generic rosuvastatin approval in 2016, and price competition has been vigorous since [1]. By 2026, the average Florida cash price at Walgreens is approximately $14.99 for a 30-count supply of rosuvastatin 10 mg [2]. Costco Pharmacy in Florida consistently offers the lowest walk-in price among large chains, often under $8 without any coupon [2].

Brand Crestor retains a place primarily when a patient's commercial insurance covers it at a lower tier than the generic, or when the AstraZeneca savings card applies. Outside those two scenarios, brand Crestor provides no clinical advantage over generic rosuvastatin. The FDA's bioequivalence standards require generics to deliver 80 to 125% of the reference drug's bioavailability within tight confidence intervals [3].

Dose-by-Dose Price Comparison

Rosuvastatin is FDA-approved at 5 mg, 10 mg, 20 mg, and 40 mg daily [4]. Higher doses do not always cost more at retail: a 30-count supply of rosuvastatin 40 mg often costs the same as 10 mg at discount pharmacies, so some patients prescribed 20 mg ask their provider about pill-splitting 40 mg tablets after confirming the tablet is not scored in a way that affects dissolution. Providers should check the specific manufacturer's scoring before recommending that approach.

The 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol states: "High-intensity statin therapy should be used in very high-risk ASCVD patients unless contraindicated" [5]. Rosuvastatin 20 to 40 mg qualifies as high-intensity therapy under those guidelines, making dose selection a clinical question before a cost question.

Florida Medicaid Coverage for Rosuvastatin

Florida Medicaid covers rosuvastatin on its preferred drug list, but with a significant restriction that surprises many patients: coverage for the hyperlipidemia indication requires a prior authorization for brand Crestor, while generic rosuvastatin is covered without prior authorization for eligible diagnoses [6]. Coverage for general hyperlipidemia or ASCVD prevention is available only for generic rosuvastatin, not brand Crestor, unless prior authorization is granted.

The Type 2 Diabetes Coverage Rule

Florida Medicaid's formulary designates rosuvastatin as a preferred statin for beneficiaries with type 2 diabetes, consistent with ADA Standards of Medical Care guidance recommending moderate-to-high-intensity statin therapy for all adults with diabetes aged 40 to 75 [7]. Patients with a primary diagnosis of hyperlipidemia without diabetes may still receive generic rosuvastatin, but approval pathways differ by managed care plan.

Florida operates its Medicaid program through managed care organizations (MCOs) including Humana, Molina, Simply Healthcare, and WellCare. Each MCO administers its own drug formulary within Florida Agency for Health Care Administration (AHCA) guidelines. A beneficiary enrolled in Molina may face different step-therapy requirements than one enrolled in WellCare, so calling the MCO directly before filling is the most reliable step [8].

Step Therapy and Prior Authorization

Florida Medicaid MCOs typically require a patient to try and "fail" simvastatin or pravastatin before approving rosuvastatin without restriction. If a prior statin caused myopathy confirmed by creatine kinase elevation, that documented adverse event typically satisfies step-therapy requirements without re-trialing [6]. Providers should attach CK lab results and clinical notes to prior authorization requests to speed approval.

Is Compounded Rosuvastatin Legal in Florida?

Compounded rosuvastatin prepared by a licensed 503A pharmacy is legal in Florida. The Florida Department of Health licenses compounding pharmacies under Chapter 465, Florida Statutes, and the Florida Board of Pharmacy enforces USP <795> and <797> standards for non-sterile and sterile preparations respectively [9]. Because rosuvastatin is available commercially as an FDA-approved product, a 503A pharmacy may compound it only pursuant to a valid, patient-specific prescription with a documented clinical rationale, consistent with FDA guidance on compounding of commercially available drugs [10].

What 503A Means for Patients

A 503A pharmacy is a traditional compounding pharmacy that fills prescriptions for individual patients. It differs from a 503B outsourcing facility, which may produce larger batches for office use [10]. Florida has dozens of licensed 503A pharmacies, and some telehealth clinics that operate in Florida arrange compounded rosuvastatin for patients who qualify, often at zero or near-zero direct cost to the patient as part of a care package.

The clinical rationale most commonly documented for compounded rosuvastatin includes: dysphagia requiring a liquid formulation, tablet coating allergies, or combination formulations pairing rosuvastatin with ezetimibe or a B-vitamin complex not commercially available as a single tablet. Prescribers must document the specific need in the patient chart.

Florida Board of Pharmacy Oversight

The Florida Board of Pharmacy conducts routine and complaint-triggered inspections of 503A compounding facilities. Pharmacies found dispensing compounded copies of commercially available drugs without adequate clinical justification face license suspension and FDA referral [9]. Patients receiving compounded rosuvastatin through a telehealth provider should verify the dispensing pharmacy's active Florida license at the AHCA provider search portal before accepting the prescription [8].

The Clinical Evidence Behind Rosuvastatin: Why Doctors Prescribe It

Rosuvastatin is a synthetic, fully hydrophilic statin that inhibits HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis [11]. Its high hepatoselectivity relative to lipophilic statins like simvastatin translates into a favorable muscle-safety profile at equivalent LDL-lowering doses.

JUPITER Trial: The Landmark Data

The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) enrolled 17,802 healthy adults with LDL <130 mg/dL but elevated high-sensitivity CRP (>2.0 mg/L) and randomized them to rosuvastatin 20 mg daily vs. Placebo [12]. At a median follow-up of 1.9 years, rosuvastatin reduced the primary endpoint (composite of MI, stroke, arterial revascularization, hospitalization for unstable angina, or CV death) by 44% (HR 0.56; 95% CI 0.46 to 0.69; P<0.00001) [12]. LDL fell by 50% in the treatment group [12].

LDL Reduction by Dose

Published meta-analyses of statin dose-response data, including the Cholesterol Treatment Trialists' (CTT) Collaboration analysis of 170,000 participants across 26 trials, confirm that each 1 mmol/L reduction in LDL cholesterol reduces major vascular events by about 22% [13]. Rosuvastatin 10 mg reduces LDL by approximately 46%; rosuvastatin 40 mg reduces LDL by approximately 55% [4].

Muscle Safety and CK Monitoring

The FDA-approved labeling for rosuvastatin notes myopathy risk, including rare rhabdomyolysis, particularly at the 40 mg dose and in Asian patients (who show approximately two-fold higher plasma concentrations) [4]. The FDA label recommends starting Asian patients at 5 mg. The ACC/AHA 2018 Guideline on Management of Blood Cholesterol advises baseline CK measurement only in patients with risk factors for myopathy, not routinely [14].

Crestor and Rosuvastatin Insurance Coverage in Florida

Commercial insurance coverage for rosuvastatin in Florida follows national formulary patterns. Most major Florida plans, including Florida Blue (Blue Cross Blue Shield of Florida), Cigna, United Healthcare, and Aetna, place generic rosuvastatin on Tier 1 or Tier 2, with copays ranging from $0 to $15 per month [15]. Brand Crestor typically sits on Tier 3 or Tier 4, where cost-sharing can reach $60, $150 per month even after insurance.

Florida Blue Formulary Specifics

Florida Blue's 2026 formulary lists generic rosuvastatin as a Tier 1 preferred generic with a $0 copay on most standard plans and a $5 copay on high-deductible health plans during non-deductible phases [15]. Brand Crestor requires a non-preferred brand exception. Patients on Florida Blue who request brand Crestor without a documented clinical reason for preferring brand over generic may be denied or asked to pay the full Tier 4 differential.

Medicare Part D in Florida

Florida has more Medicare Part D enrollees than nearly any other state. Under the Inflation Reduction Act's 2026 provisions, Part D out-of-pocket costs for covered drugs are capped at $2,000 annually, and rosuvastatin remains broadly covered by Part D plans operating in Florida [16]. The Low Income Subsidy (Extra Help) program reduces or eliminates copays for rosuvastatin for qualifying beneficiaries. Patients can compare Part D plans covering rosuvastatin at the Medicare Plan Finder tool at cms.gov.

Marketplace (ACA) Plans in Florida

Florida has the highest ACA marketplace enrollment in the country. Silver-tier marketplace plans in Florida typically cover generic rosuvastatin at $10, $20 per month after the deductible. Bronze plans may require patients to pay the full cash price until the deductible is met, making GoodRx coupons more practical for bronze enrollees who are not near their deductible [17].

How to Get Rosuvastatin via Telehealth in Florida

Florida law permits telehealth prescribing of rosuvastatin. The Florida Telehealth Act (s. 456.47, Florida Statutes) allows licensed practitioners to prescribe medications, including controlled and non-controlled substances, following a synchronous audio-video encounter that satisfies the standard of care [18]. Prescribing rosuvastatin without a prior in-person visit is legally permissible as long as the provider conducts an appropriate clinical evaluation.

What a Telehealth Rosuvastatin Visit Looks Like

A standard telehealth lipid visit in Florida takes 15 to 20 minutes. The provider reviews lipid panel results (typically ordered in advance or uploaded by the patient), calculates 10-year ASCVD risk using the Pooled Cohort Equations endorsed by ACC/AHA guidelines [14], documents the clinical indication, and sends the prescription electronically to the patient's pharmacy of choice. Most telehealth platforms operating in Florida also offer integrated lab ordering through Quest or Labcorp, so baseline LFT and CK values can be obtained before or just after prescribing.

HealthRX Telehealth Rosuvastatin Pathway in Florida

HealthRX providers in Florida follow a standardized lipid management protocol: confirm fasting lipid panel within 12 months, calculate PCE-based ASCVD risk, select statin intensity per ACC/AHA 2018 guidelines [14], and send rosuvastatin to the patient's preferred pharmacy or a partnered 503A compounder. Follow-up lipid panels are ordered at 6 to 12 weeks post-initiation per guideline recommendations [14]. Patients with baseline LDL >190 mg/dL are flagged for familial hypercholesterolemia evaluation before finalizing dose.

Prescription Validity and Refills

A Florida telehealth rosuvastatin prescription carries the same legal validity as one written in person. Pharmacies may not refuse to fill a telehealth prescription solely because it originated from a telemedicine encounter, per Florida Board of Pharmacy guidance [9]. Most providers write 90-day supplies with three refills, reducing pharmacy trips and frequently unlocking a lower per-unit price at mail-order pharmacies.

The Cheapest Ways to Get Rosuvastatin in Florida

Getting rosuvastatin for under $15 per month in Florida is achievable through at least four distinct routes, and getting it for free or near-free is possible for qualifying patients.

GoodRx and Coupon Aggregators

GoodRx, RxSaver, and NeedyMeds aggregate pharmacy discount codes that bypass insurance and apply directly to the cash price. At Publix in Miami, GoodRx shows rosuvastatin 10 mg (30 tablets) for approximately $9.19 as of early 2026. At Walmart in Orlando, the price with GoodRx is approximately $8.47. These coupons cannot be combined with insurance at the same transaction but are often better than a Tier 2 copay for patients on high-deductible plans [2].

AstraZeneca Savings Card for Brand Crestor

AstraZeneca offers a savings card that reduces brand Crestor to as low as $0 for commercially insured patients and a fixed monthly maximum for uninsured patients. The card is available at crestor.com and applies at participating Florida pharmacies. Patients on Medicare or Medicaid are not eligible for manufacturer savings cards under federal anti-kickback statute provisions [19]. The savings card is most useful for commercially insured patients whose plan places brand Crestor on a non-preferred tier.

Mark Cuban's Cost Plus Drugs

Cost Plus Drugs (CostPlusDrugs.com) lists rosuvastatin 10 mg at $4.80 for 30 tablets as of 2026, with free shipping to Florida addresses. The platform operates on a transparent markup model (cost plus 15% plus a $3 pharmacy fee) and does not require insurance [2]. Prescriptions must be transferred or newly written to Cost Plus Drugs' dispensing pharmacy.

Patient Assistance Programs

AstraZeneca's AZ&Me Prescription Savings Program provides brand Crestor at no cost to uninsured or underinsured patients meeting income criteria (generally at or below 600% of the federal poverty level) [19]. Applications are submitted at azandmeenrollment.com. Processing typically takes 2 to 4 weeks, and approval covers a 90-day supply mailed directly to the patient.

Rosuvastatin Dosing and Safety Essentials

Starting Doses and Titration

The FDA-approved starting dose for most adults is rosuvastatin 10 mg once daily for moderate-intensity therapy and 20 mg once daily for high-intensity therapy [4]. Titration to 40 mg is appropriate when LDL reduction targets are not met at 20 mg. The 80 mg dose is not FDA-approved due to increased myopathy risk observed in pre-approval studies, distinguishing rosuvastatin from simvastatin, which the FDA restricted to 80 mg in 2011 [20].

Drug Interactions Relevant to Florida Patient Populations

Rosuvastatin plasma levels rise significantly with cyclosporine (8-fold), gemfibrozil (1.9-fold), and lopinavir/ritonavir (2-fold) [4]. The FDA label recommends a maximum rosuvastatin dose of 10 mg daily in patients taking cyclosporine [4]. Given Florida's large HIV-positive population receiving antiretroviral therapy, providers prescribing rosuvastatin via telehealth should review the patient's full medication list before finalizing dose.

Pregnancy and Lactation

Rosuvastatin is contraindicated in pregnancy (FDA Pregnancy Category X under the legacy system; labeled as avoid use in current labeling) and is not recommended during breastfeeding [4]. Florida has a high proportion of women of reproductive age using telehealth platforms, so providers should confirm pregnancy status and contraception use before initiating therapy. ACOG recommends discontinuing statins as soon as pregnancy is recognized [21].

Comparing Rosuvastatin to Other Statins Available in Florida

Rosuvastatin is not the only high-intensity statin option. Atorvastatin 40 to 80 mg achieves similar LDL reductions (45 to 55%) and is available at comparable or lower cash prices at Florida pharmacies [5]. The CTT Collaboration data show no significant difference in cardiovascular outcomes between atorvastatin and rosuvastatin at equivalent LDL-reducing intensities [13]. Rosuvastatin's primary clinical advantages are its hydrophilicity, which reduces CYP3A4-mediated drug interactions compared to atorvastatin, and its once-daily dosing efficacy at lower mg amounts.

Pitavastatin offers an alternative for patients with statin-associated muscle symptoms (SAMS) and has a distinct metabolic profile, but generic pitavastatin costs more than generic rosuvastatin in Florida, averaging $45, $60 per month without coupons [2]. Pravastatin and simvastatin are low-intensity options priced comparably to rosuvastatin but provide less LDL reduction per milligram [5].